Cardiac complications is a major cause of mortality in patients with type-2 diabetes. Lookout for cardiovascular problems, medications that prevent cardiovascular problems, and drugs that will have either neutral or beneficial effects on cardiovascular disease are few of the points associated with controlling the chronic complications of diabetes.
In addition, other comorbidities associated with cardiovascular complications can be controlled using SGLT-2 receptor blockers that produce natriuresis, take off volume overload, reduce weight, and reduce nephrotoxic problems beyond control. This session will cover: Salient aspects of cardiovascular diseases in type-2 diabetes Management of cardiovascular risk in type-2 diabetes Features of EMPA-REG Outcome Study that Improve Management of type-2 diabetes Cardiovascular outcomes that may be expected with Empagliflozin Conditions to optimize…
